Your session is about to expire
← Back to Search
Metoclopramide for Hypoglycemia Unawareness
Study Summary
This trial will test whether the drug metoclopramide can help type 1 diabetes patients who have hypoglycemia unawareness by improving their hypoglycemia awareness and decreasing the incidence of hypoglycemia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have Type 1 Diabetes Mellitus.My liver disease is in an advanced stage.My hemoglobin level is below 11 g/dL.I cannot take metoclopramide due to allergies, certain health conditions, or recent use of specific medications.Your hemoglobin A1c level is less than or equal to 9%.You have participated in another study for low blood sugar awareness or related issues in the past month.I have a history of heart issues, including heart attack, irregular heartbeat, heart failure, or poor blood flow in my heart arteries.I have had diabetes for more than 5 years.You have had an allergic reaction or bad side effects from using heparin before.You are currently using a continuous glucose monitoring system that provides real-time data.I often need to take acetaminophen for pain or fever.I have had issues with blocked urine flow or not being able to urinate.I do not have uncontrolled mania or active major depression.I have had a stroke or brain disease in the past.I am not pregnant, breastfeeding, and can use effective birth control during the study.
- Group 1: T1DM - Unaware: Placebo
- Group 2: T1DM - Aware: Placebo
- Group 3: T1DM - Unaware: Metoclopramide
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to join the research protocol?
"This clinical trial requires a diagnosis of hypoglycemia and an age between 20 to 60 years old. At the moment, 36 applicants are being accepted into this medical study."
Are there any openings left for participants in this clinical trial?
"According to the information accessible on clinicaltrials.gov, this medical trial is actively seeking participants and has been open since May 28th 2019 with edits made as recently as September 20th 2022."
What is the aggregate figure of participants enrolled in this clinical trial?
"Indeed, current information on clinicaltrials.gov suggests that this medical trial is in the process of recruiting candidates. Initially posted on May 28th 2019, it was recently updated on September 20th 2022 and requires 36 volunteers at a single location."
Is the current enrollment in this experiment restricted to individuals over 45 years of age?
"The entrance qualifications for this medical trial stipulate a minimum age of 20 and an upper limit of 60."
Under what circumstances is Metoclopramide typically recommended?
"Metoclopramide is a well-known therapeutic agent used to treat the aforementioned medical procedure, as well as gastric motility disorder, gastroparesis and other forms of radiologic procedures."
Is Metoclopramide a safe and efficacious treatment to utilize?
"Metoclopramide has been deemed a level two based on the fact that there is some evidence of its safety, but no empirical proof for efficacy."
Share this study with friends
Copy Link
Messenger